However, SIRT1 overexpression led to recovery of impaired vascular dysfunction by reducing eNOS acetylation and elevating its bioavailability, which suggests that SIRT1 is a key modulator of CRIF1 deficiency-induced endothelial dysfunction. The gene discussed is NOS3; the disease is endothelial dysfunction.